Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Adefovir Dipivoxil/Lamivudine

Home DrugsAdefovir Dipivoxil/Lamivudine

Adefovir Dipivoxil/Lamivudine

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Drug composition containing dioxide fluosulfocytosine, lamivudine and Adefovir dipivoxil
Applicant: LAI QINGLIANPriority: 2002
CN
Adefovir dipivoxil tablet for treating hepatitis B and preparation method thereof
Applicant: 302 MILITARY OF CHINAPriority: 2013
CN
Novel pharmaceutical compositions
Applicant: GLAXO WELLCOME MFG PTE LTDPriority: 2011
CN
PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING HEPATITIS
Applicant: SEECURE TAIWAN CO LTDPriority: 2025
US
Medicine composition containing alfa-interferon , lamivudine and adefovir
Applicant: LAI QINGLIANPriority: 2002
CN
Composition for treating hepatitis B and application thereof
Applicant: ZHANG CAIYINGPriority: 2024
CN